FOLFOX in Combination with Binimetinib as 2nd Line Therapy for Patients with Advanced Biliary Tract Cancers with MAPK Pathway Alterations: A ComboMATCH Treatment Trial
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
8940 N. Wood Sage Rd | Peoria, IL 61615-7822
